Career & Filing History
Every role James Jones has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
James Jones is Director at CUMBERLAND PHARMACEUTICALS INC (CPIX). Jones has reported 14 insider filings with the SEC since 2024. The most recent filing was in March 2026.
Every role James Jones has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
CUMBERLAND PHARMACEUTICALS INC (CPIX)14 filingsLatest filing:
James Jones is Director of CUMBERLAND PHARMACEUTICALS INC (CPIX). 14 SEC Form 4 filings on record going back to 2024, most recently on 20 March 2026. Lifetime open-market purchases: $10K. Historical track record: 4/5 stars across 184 tracked purchases.
Every recent SEC Form 4 transaction James Jones has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 184 |
| Purchases with forward-return data | 184 |
| 30-day win rate | 52% |
| 90-day win rate | 43% |
| Avg 5-day return | +1.46% |
| Avg 30-day return | +7.37% |
| Avg 90-day return | +47.96% |
| Best 30-day return |
InsiderAlpha's records for James Jones go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. The typical open-market purchase is $56 (184 buys totaling $10K). The largest single buy on record is $108 of CPIX in 2024. 141 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Insiders who have reported open-market trades at the same companies as James Jones. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
James Jones is a corporate insider, tracked as Director of CUMBERLAND PHARMACEUTICALS INC (CPIX). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 20 March 2026, one of 14 filings going back to 2024.
Recorded transactions: 184 open-market purchases ($10K) and 0 open-market sales across all tracked filings.
Across 184 tracked purchases, James Jones averaged +7.4% avg 30-day return with a 52% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
| +121.70% |